Hanlan, James P.
WASH / Washington, DC, Project Center
The purpose of this project was to provide the United States Food & Drug Administration with an evaluation of the possible use of unique facility identifiers within the drug adverse event reporting system. Through interviews, research, and database demonstrations, we identified current shortcomings in the availability of facility information and proposed a future state which would expedite investigations of public health signals. A gap analysis was then utilized to develop proposed policy, informatics, and process changes to improve FDA.
Worcester Polytechnic Institute
Interactive Qualifying Project
All authors have granted to WPI a nonexclusive royalty-free license to distribute copies of the work, subject to other agreements. Copyright is held by the author or authors, with all rights reserved, unless otherwise noted.
Humanities and Arts